NCT06061549View on ClinicalTrials.gov

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2029

Conditions
Heart Failure, DiastolicHeart Failure With Preserved Ejection Fraction
Interventions
BIOLOGICAL

AAV1/SERCA2a

3E13 viral genomes fixed dose

Trial Locations (2)

27705

RECRUITING

Duke University, Durham

75390

NOT_YET_RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

Sardocor Corp.

INDUSTRY